An innovative initiative has caught attention in Europe. Tomorrow.Bio is the first company on the continent to offer cryonics services, with an interesting waiting list that already has around 700 people. The company's goal is to preserve individuals through freezing or cryopreservation, with the hope that in the future, when science has progressed, their diseases will be treatable.
The cryonics process costs $200,000 and is considered a significant investment in what the company describes as "preservation of life potential." It is carried out immediately after death, with the aim of minimizing cellular damage. It involves completely replacing the blood circulation with a specifically designed cryoprotectant solution, and then gradually cooling to reach extremely low temperatures of -196°C.
The effectiveness of this process has been proven by Tomorrow.Bio, as they have successfully cryopreserved seven people and four pets. This achievement represents an important milestone in the field of cryogenics in Europe. Thanks to the characteristics of the procedure and technological advancements, it is possible to maintain cryopreservation indefinitely.
